Juliane Paul

Title: The Innovative Contributions of Juliane Paul

Introduction

Juliane Paul is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lymphomas. With a total of 2 patents, her work is paving the way for new therapeutic options.

Latest Patents

Juliane Paul's latest patents focus on the use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treating various forms of lymphomas. The first patent describes pharmaceutical combinations and compositions that include a 2,3-dihydroimidazo[1,2-c]quinazoline compound, or a salt thereof, along with additional active agents. These combinations are particularly useful for treating non-Hodgkin's lymphoma (NHL) in its various forms, including aggressive and indolent types. The second patent outlines methods for administering these compounds to patients in need, targeting specific types of NHL and other related lymphomas.

Career Highlights

Juliane Paul is currently employed at Bayer Pharma Aktiengesellschaft, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a strong focus on developing effective treatments for complex medical conditions.

Collaborations

Juliane collaborates with esteemed colleagues, including Ningshu Liu and Katja Haike, who contribute to her research and development efforts.

Conclusion

Juliane Paul's innovative work in the pharmaceutical industry exemplifies the impact of dedicated inventors on medical advancements. Her contributions are vital in the ongoing fight against lymphomas, showcasing the importance of research and collaboration in developing effective treatments.